Macrophage Activation Syndrome Flashcards

1
Q

MAS is caused by excessive activation & expansion of what cells

A

Macrophages and T cells (predominantly CD8+)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Pathognomonic feature of MAS

A

Pathological hemophagocytosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

T/F Pathological hemophagocytosis is sensitive for overall diagnosis of MAS

A

F

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

T/F Pathological hemophagocytosis is specific for MAS

A

F

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Rheumatic disease where MAS is seen most commonly

A

sJIA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Other common rheumatic diseases associated with MAS other than sJIA

A

SLE and KD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

T/F MAS occurring at initial presentation of a rheumatic disease is not uncommon

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

MC trigger of MAS in patients with rheumatic disease

A

Viral illnesses, particularly EBV and other members of the herpes family

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Drugs most commonly implicated as triggers for MAS in patients with rheumatic disease

A

Gold, MTX, sulfasalazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cells with deficient function in MAS

A

NK cell
Cytotoxic T cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cytokines implicated in MAS pathophysiology

A

IFN-γ and IL-18

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cytokine implicated in MAS which is a well-known macrophage activator

A

IFN-γ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Anti-IFN-γ monoclonal antibody approved in the US (2018) for treatment of pediatric HLH

A

Emapalumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

T/F MAS is often associated with a flare of underlying sJIA rather than infection

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

IL-18 is known for its ability to

A

Amplify lymphocyte production of IFN-γ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Patients with sJIA and high levels of this cytokine more often have systemic manifestations rather than arthritis, and are also more likely to develop MAS

A

IL-18

17
Q

There is high expression of this scavenger receptor in hemophagocytic macrophages in MAS

A

CD163

18
Q

Receptor expressed by hemophagocytic macrophages in MAS whose best known function is related to its ability to bind hemoglobin-haptoglobin complexes and initiate pathways important for adaptation to oxidative stress induced by free heme and iron

A

CD163

19
Q

Receptor expressed by hemophagocytic macrophages in MAS associated with hyperferritinemia

A

CD163

20
Q

Decrease in this cell count is usually an early finding in MAS

A

Platelet

21
Q

T/F Cytopenias in MAS is due to decreased production

A

F, increased destruction peripherally

22
Q

T/F Liver involvement is not common in MAS

A

F, common

23
Q

T/F Significant hepatomegaly is frequently present in MAS

A

T